Health Care Industry Shaken After UnitedHealthcare CEO Is Killed Outside NYC Hotel

The motive for the shocking murder of Brian Thompson in New York City was still unknown Wednesday afternoon.

United Healthcare CEO Brian Thompson was shot early 4 December in New York City. (Shutterstock)

UnitedHealthcare CEO Brian Thompson was shot and killed outside the New York Hilton Midtown hotel on 4 December, ahead of the annual investor day held by UnitedHealth Group, New York Police Department officials confirmed, shocking the health care world.

More from Market Access

AI Could Be Used ‘In The Deliberation’ Of HTA Reviews In England, Says NICE

 

England’s health technology assessment institute, NICE, is looking to “reimagine” its evaluation process with the help of AI, rather than just using this technology to speed up its existing processes.

Dramatic HHS Layoffs A Response To ‘Existential Crisis,’ Kennedy Advisor Argues

 
• By 

Calley Means defended reductions in force at the Health and Human Services Department that shocked and outraged federal workers and stakeholders.

Brazilian Drug Price Increase Rates Hit Eight-Year Low

 

CMED, which sets medicine prices in Brazil, has published the maximum price adjustment index for 2025.

England’s NICE Wants Industry Involvement In HTA Sandbox Projects

 

Pharmaceutical companies are being encouraged to reach out to NICE in relation to its HTA Innovation Lab, which provides a sandbox environment in which the health technology assessment body can test new methods of evaluating “innovative and disruptive” therapies.

More from PBMs

PhRMA Still All In For Trump Despite Chaos Hitting US Health Sector

 

The pharmaceutical industry has been quiet on Trump's early federal government overhauls that could harm the drug business, still betting he will help produce better results than Biden.

Incoming US FTC Chair Endorses Agency Report Challenging PBM Generic Drug Markups

 
• By 

Chairman-designee Andrew Ferguson likely will continue the commission’s investigation of PBMs during the next administration.

This Year, PBM-Directed Fury May Once Again Signify Nothing

 
• By 

Anti-PBM sentiment continues to rise, but industry observers still question whether the reforms being discussed will be effective.